Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial
Yun Yen, Warren Chow, Lucille Leong, et al.
Frontiers in Oncology
|
January 31, 2020
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
Ann W Silk, Howard L Kaufman, Brendan Curti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2025
A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy
Debarati Bhanja, Junjia Zhu, Hannah Wilding, et al.
The Lancet. Oncology
|
March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Journal of Clinical Laboratory Analysis
|
August 26, 2003
Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products
Agnes Juhasz, Paul Frankel, Catherine Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics
Robert J Morgan, James H Doroshow, Timothy Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
Brian I Rini, M Dror Michaelson, Jonathan E Rosenberg, et al.
Cancer Chemotherapy and Pharmacology
|
April 16, 2003
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies
Robert J Morgan, Edward M Newman, Lawrence Sowers, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 26, 2007
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
Brian Kavanagh, Andrew Ko, Alan Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy
George Somlo, Paul Frankel, Warren Chow, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Cancer Chemotherapy and Pharmacology
|
November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial
Yun Yen, Warren Chow, Lucille Leong, et al.
Frontiers in Oncology
|
January 31, 2020
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
Ann W Silk, Howard L Kaufman, Brendan Curti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2025
A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy
Debarati Bhanja, Junjia Zhu, Hannah Wilding, et al.
The Lancet. Oncology
|
March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Journal of Clinical Laboratory Analysis
|
August 26, 2003
Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products
Agnes Juhasz, Paul Frankel, Catherine Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics
Robert J Morgan, James H Doroshow, Timothy Synold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
Brian I Rini, M Dror Michaelson, Jonathan E Rosenberg, et al.
Cancer Chemotherapy and Pharmacology
|
April 16, 2003
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies
Robert J Morgan, Edward M Newman, Lawrence Sowers, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 26, 2007
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
Brian Kavanagh, Andrew Ko, Alan Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy
George Somlo, Paul Frankel, Warren Chow, et al.
Page
of 10